Literature DB >> 6763965

A study of continuous bacillaemia in borderline and lepromatous type of leprosy.

S N Raval, U Sengupta, G Ramu, P V Prabhune, K V Desikan.   

Abstract

The present work has established beyond doubt that bacillaemia occurs practically in all cases of borderline and lepromatous leprosy. The number of bacilli in the blood is significantly high, to the tune of 4,000 bacilli per ml. Even so, it does not produce any adverse symptoms of septicaemia. Special emphasis was laid in the present study for determining the continuity or otherwise of bacillaemia. Some of the patients had continuous bacillaemia according to the criteria fixed in the present study. It was also found that the number of bacilli discharged into the blood bears no relationship with the bacillary load in the body as assessed by skin and nasal smears.

Entities:  

Mesh:

Year:  1982        PMID: 6763965

Source DB:  PubMed          Journal:  Lepr India        ISSN: 0024-1024


  3 in total

1.  Brain and Spinal Cord Lesions in Leprosy: A Magnetic Resonance Imaging-Based Study.

Authors:  Kiran Polavarapu; Veeramani Preethish-Kumar; Seena Vengalil; Saraswati Nashi; Mallika Lavania; Kajari Bhattacharya; Anita Mahadevan; Thagadur Chickabasaviah Yasha; Jitender Saini; Utpal Sengupta; Shumyla Jabeen; Bevinahalli N Nandeesh; Itu Singh; Niranjan P Mahajan; Chevula Pradeep-Chandra-Reddy; Gareth J Parry; Atchayaram Nalini
Journal:  Am J Trop Med Hyg       Date:  2019-04       Impact factor: 2.345

2.  Structural aspects of lesional and non-lesional skin microbiota reveal key community changes in leprosy patients from India.

Authors:  Nitin Bayal; Sunil Nagpal; Mohammed Monzoorul Haque; Milind S Patole; Yogesh Shouche; Shekhar C Mande; Sharmila S Mande
Journal:  Sci Rep       Date:  2021-02-08       Impact factor: 4.379

Review 3.  Treatment and Evaluation Advances in Leprosy Neuropathy.

Authors:  Gigi J Ebenezer; David M Scollard
Journal:  Neurotherapeutics       Date:  2021-11-19       Impact factor: 7.620

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.